Work

Supplementary Figure 3 from SMURF2 Facilitates GAP17 Isoform 1 Membrane Displacement to Promote Mutant p53–KRAS Oncogenic Synergy

Year: 2025

Type: supplementary-materials

Abstract: S3. SMURF2 overexpression has no significant effects on disease-free survival of PDA patients following adjuvant therapy.

DOI: 10.1158/1541-7786.29221217

Authors: Paramita Ray, Shirish Shukla, Yaqing Zhang, Katelyn L. Donahue, Derek J. Nancarrow, Srimathi Kasturirangan, Sunita Shankar, Kyle Cuneo, Dafydd Thomas, Shirish M. Gadgeel, Theodore S. Lawrence, Marina Pasca di Magliano, Dipankar Ray

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4411005685

Cites:

Cited by:

Related to: 10